XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 3 Months Ended 8 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2020
Sep. 30, 2021
Cash Flows from Operating Activities        
Net income (loss)     $ (9,432,442) $ 23,962,075
Adjustments to reconcile net income (loss) to net cash used in operating activities        
Change in fair value warrants $ (6,880,500) $ (1,529,000) 2,548,333 (16,054,501)
Change in fair value of FPA 0 2,299,616 5,293,037 (7,494,372)
Gain on termination of FPA       (3,160,168)
Transaction costs incurred in connection with IPO     1,381,051  
Changes in operating assets and liabilities:        
Prepaid expenses     (256,808) 87,915
Accounts payable and accrued expenses     110,051 1,542,515
Net cash used in operating activities     (356,778) (1,116,536)
Cash Flows from Investing Activities:        
Investment of cash in Trust Account     (517,500,000)  
Net cash used in investing activities     (517,500,000)  
Cash Flows from Financing Activities        
Proceeds from sale of Units, net of underwriting discounts paid     507,150,000  
Proceeds from sale of Private Placement Warrants     12,350,000  
Proceeds from issuance of Class B ordinary shares to Sponsor     25,000  
Proceeds from promissory note - related party     150,000 450,000
Repayment of promissory note - related party     (150,000)  
Payment of offering costs     (778,589)  
Net cash provided by financing activities     518,746,411 450,000
Net Change in Cash     889,633 (666,536)
Cash - Beginning       843,643
Cash - Ending $ 177,107 $ 889,633 889,633 $ 177,107
Supplemental disclosure of non-cash investing and financing activities:        
Initial classification of ordinary shares subject to possible redemption     517,500,000  
Deferred underwriting fee payable     $ 18,112,500